glp 1 and anesthesia A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general GLP-1 Receptor Agonists and Gastrointestinal

This means: Less data may be available about long-term safety compared to FDA-approved drugs Formulation variations may exist between batches Quality control standards differ from FDA-approved manufacturing Individual responses may vary more than with standardized branded medications Patients should discuss these considerations with their clinician and ensure they understand the distinction between FDA-approved and compounded medications

Secondary searches were performed using Google Scholar and regulatory sources, e.g., US Food and Drug Administration (FDA) labels and European Medicines Agency (EMA) reports, to capture gray literature and pharmacovigilance data

GLP-1 AI

Importantly, they noted that these mental health improvements had not occurred when they had achieved this level of weight loss in the past through other means e.g

Many patients carry years of frustration or shame, she said

Patients were excluded if they had thyroid cancer at any time before cohort entry, any other cancer in the previous year, end stage illness, human immunodeficiency virus infection, drug or alcohol misuse in the previous year, major pancreatic disease, genetic syndromes associated with thyroid cancer, and no healthcare contact in the previous year (to ensure a minimum level of activity in the healthcare system